01:24 PM EDT, 07/19/2024 (MT Newswires) -- Artiva Biotherapeutics (ARTV) shares debuted on Nasdaq Friday with an opening price of $16, above the initial public offering price of $12.

The shares were most recently changing hands at $13.89 apiece, up 16% from the IPO price.

The company is offering 13.9 million common shares at $12 per share for gross proceeds of about $167 million.

Underwriters have been granted a 30-day option to purchase up to about 2.1 million additional common shares.

Price: 13.89, Change: +1.89, Percent Change: +15.75